PUBLICATION

The identification of dual protective agents against cisplatin-induced oto-and nephrotoxicity using the zebrafish model

Authors
Wertman, J.N., Melong, N., Stoyek, M.R., Piccolo, O., Langley, S., Orr, B., Steele, S.L., Razaghi, B., Berman, J.N.
ID
ZDB-PUB-200729-6
Date
2020
Source
eLIFE   9: (Journal)
Registered Authors
Berman, Jason, Langley, Stewart, Melong, Nicole, Piccolo, Olivia, Razaghi, Babak, Stoyek, Matthew, Wertman, Jaime
Keywords
cancer biology, human, human biology, medicine, zebrafish
MeSH Terms
  • Cisplatin*/pharmacology
  • Cisplatin*/toxicity
  • Antineoplastic Agents/pharmacology
  • Antineoplastic Agents/toxicity
  • Zebrafish
  • Drug Combinations
  • Animals
  • Dopamine/pharmacology
  • Cell Line, Tumor
  • Hair Cells, Auditory/drug effects
  • Hair Cells, Auditory/pathology
  • Lateral Line System/drug effects
  • Lateral Line System/pathology
  • Humans
  • Models, Animal
  • Kidney/drug effects
  • Kidney/pathology
  • Mimosine/pharmacology
  • Protective Agents/pharmacology*
(all 19)
PubMed
32720645 Full text @ Elife
Abstract
Dose-limiting toxicities for cisplatin administration, including ototoxicity and nephrotoxicity, impact the clinical utility of this effective chemotherapy agent and lead to lifelong complications, particularly in pediatric cancer survivors. Using a two-pronged drug screen employing the zebrafish lateral line as an in vivo readout for ototoxicity and kidney cell-based nephrotoxicity assay, we screened 1280 compounds and identified 22 that were both oto- and nephroprotective. Of these, dopamine and L-mimosine, a plant-based amino acid active in the dopamine pathway, were further investigated. Dopamine and L-mimosine protected the hair cells in the zebrafish otic vesicle from cisplatin-induced damage and preserved zebrafish larval glomerular filtration. Importantly, these compounds did not abrogate the cytotoxic effects of cisplatin on human cancer cells. This study provides insights into the mechanisms underlying cisplatin-induced oto- and nephrotoxicity and compelling preclinical evidence for the potential utility of dopamine and L-mimosine in the safer administration of cisplatin.
Genes / Markers
Figures
Figure Gallery (11 images) / 2
Show all Figures
Expression
No data available
Phenotype
No data available
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
a9
    		Complex
    w2
      		Point Mutation
      1 - 2 of 2
      Show
      Human Disease / Model
      No data available
      Sequence Targeting Reagents
      No data available
      Fish
      No data available
      Antibodies
      No data available
      Orthology
      No data available
      Engineered Foreign Genes
      No data available
      Mapping
      No data available
      Your Input Welcome
      We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
      Citation
      Wertman, J.N., Melong, N., Stoyek, M.R., Piccolo, O., Langley, S., Orr, B., Steele, S.L., Razaghi, B., Berman, J.N. (2020) The identification of dual protective agents against cisplatin-induced oto-and nephrotoxicity using the zebrafish model. eLIFE. 9:.